A comprehensive review and meta-analysis of the association between thyroid disorders and the risk of liver cancer development - Report - MDSpire

A comprehensive review and meta-analysis of the association between thyroid disorders and the risk of liver cancer development

  • By

  • Omid Asbaghi

  • Ghazaleh Shimi

  • Arman Ghorbani

  • Hamid Zand

  • December 4, 2025

  • 0 min

Share

Clinical Report: Thyroid Disorders and Liver Cancer Risk: A Meta-Analysis

Overview

This systematic review and meta-analysis investigates the association between thyroid disorders, specifically hypothyroidism and hyperthyroidism, and the risk of liver cancer. The findings suggest that hypothyroidism is linked to an increased risk of liver cancer, while hyperthyroidism does not show a significant association.

Background

Thyroid disorders are prevalent endocrine conditions that can significantly impact metabolic processes and overall health. Liver cancer is a leading cause of cancer-related mortality worldwide, and understanding potential risk factors, including thyroid dysfunction, is crucial for prevention and management strategies. This study aims to clarify the relationship between thyroid disorders and liver cancer risk, contributing to the body of evidence in this area.

Data Highlights

No numerical data available in the source material.

Key Findings

  • Hypothyroidism is associated with an increased risk of liver cancer, with a combined effect size of 1.45 (95% CI 1.08–1.95).
  • Hyperthyroidism does not show a significant association with liver cancer risk.
  • Thyroid hormones influence hepatic metabolism, which may contribute to liver carcinogenesis.
  • Chronic inflammation and oxidative stress linked to thyroid dysfunction may predispose the liver to cancer.
  • Observational studies have produced inconsistent results regarding the relationship between thyroid disorders and liver cancer.

Clinical Implications

Healthcare professionals should consider thyroid function when assessing liver cancer risk in patients, particularly those with hypothyroidism. Monitoring and managing thyroid disorders may be beneficial in reducing potential liver cancer risk factors.

Conclusion

The findings underscore the importance of recognizing thyroid dysfunction as a potential risk factor for liver cancer, particularly hypothyroidism. Further research is warranted to explore the underlying mechanisms and confirm these associations.

References

  1. A systematic review and meta-analysis examining the relationship between hyperthyroidism or hypothyroidism and the probability of developing liver cancer | BMC Cancer | Springer Nature Link
  2. EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
  3. Association of Multifocal Papillary Thyroid Cancer and Hashimoto's Thyroiditis with Increased Risk of Lymph Node Metastasis
  4. Evaluating the Diagnostic Performance of Thyroglobulin in Fine-Needle Aspiration Washout of Lymph Nodes: A Comprehensive Review and Meta-Analysis
  5. Subclinical Hypothyroidism as a Distinct Predictor of Cardiovascular Outcomes in Patients with Left Ventricular Thrombus
  6. The Journal of Clinical Endocrinology & Metabolism — Genetic Influences on Thyroid Activity: Implications for Biological Understanding and Clinical Treatment
  7. EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
  8. A systematic review and meta-analysis examining the relationship between hyperthyroidism or hypothyroidism and the probability of developing liver cancer | BMC Cancer | Springer Nature Link

Original Source(s)

Related Content